PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
ACA
PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s XBI Position: Q2 2024 in Review
PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2024, closing a stake of 118 shares — an estimated $11.2K sold.
PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in XBI in Q4 2023 and held it in 2 quarters. The position peaked at $11.2K in Q1 2024. 761 funds tracked by Wall St. Rank hold XBI as of Q2 2024.
- PENSION & WEALTH MANAGEMENT ADVISORS, INC. reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2024 after selling out during the quarter.
- PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold 118 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $11.2K.
- PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and held it in 2 quarters.
- PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s State Street SPDR S&P Biotech ETF position peaked at $11.2K in Q1 2024.
- 761 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.
Based on PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s 13F filing for Q2 2024, filed 7 Aug 2026.